SomaLogic is committed to rapid publication of our scientific findings in the peer-reviewed literature.
Below is a chronological list of select articles by SomaLogic scientists and their collaborators.
Download an annotated publications list that includes articles from users of SomaLogic’s proteomic technology.
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight (2020) SJ Lee, A Lehar, JU Meir, C Koch, A Morgan, LE Warren, R Rydzik, DW Youngstrom, H Chandok, J George, J Gogain, M Michaud, TA Stoklasek, Y Liu and EL Germain-Lee.
Proceedings of the National Academy of Sciences U S A, epub ahead of print.
Impact of kidney function on the blood proteome and on protein cardiovascular risk biomarkers in patients with stable coronary heart disease (2020) J Yang, EN Brody, AC Murthy, RE Mehler, SJ Weiss, RK Delisle, R Ostroff, SA Williams and P Ganz.
Journal of the American Heart Association 9(15): e016463
Also see accompanying editorial:
Getting to the heart and soul of chronic kidney disease (2020) FK Khalaf, P Dube, CJ Mohammed and DJ Kennedy.
Journal of the American Heart Association 9(15): e017427
Mechanisms of sodium–glucose cotransporter 2 inhibition: insights from large-scale proteomics (2020) E Ferrannini, AC Murthy, Y Lee, E Muscelli, S Weiss, RM Ostroff, N Sattar, SA Williams and P Ganz.
Diabetes Care 43(9): 2183-2189 (SUBSCRIPTION REQUIRED)
Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure (2020) JA Chirinos, L Zhao, Y Jia, C Frej, L Adamo, D Mann, SV Shewale, JS Millar, DJ Rader, B French, J Brandimarto, KB Margulies, JS Parks, Z Wang, DA Seiffert, J Fang, N Sweitzer, C Chistoffersen, B Dahlback, BD Car, DA Gordon, TP Cappola and A Javaheri.
Circulation 141(18): 1463-1476 (SUBSCRIPTION REQUIRED)
Single-molecule super-resolution microscopy reveals heteromeric complexes of MET and EGFR upon ligand activation (2020) MIE Harwardt, MS Schröder, Y Li, S Malkusch, P Freund, S Gupta, N Janjic, S Strauss, R Jungmann, MS Dietz and M Heilemann.
International Journal of Molecular Sciences 21: 2803
Modified nucleotides may have enhanced early RNA catalysis (2020) SK Wolk, WS Mayfield, AD Gelinas, D Astling, J Guillot, EN Brody, N Janjic and L Gold.
Proceedings of the National Academy of Sciences USA 117(15): 8236-8242
Coronary artery disease and type 2 diabetes: a proteomic study (2020) G Ferrannini, ML Manca, M Magnoni, F Andreotti, D Andreini, R Latini, A Maseri, AP Maggioni, RM Ostroff, SA Williams and E Ferrannini.
Diabetes Care 43(4): 843-851 (SUBSCRIPTION REQUIRED)
Plasma protein patterns as comprehensive indicators of health (2019) SA Williams, M Kivimaki, C Langenberg, AD Hingorani, JP Casas, C Bouchard, C Jonasson, MA Sarzynski, MJ Shipley, L Alexander, J Ash, T Bauer, J Chadwick, G Datta, RK DeLisle, Y Hagar, M Hinterberg, R Ostroff, S Weiss, P Ganz and N Wareham.
Nature Medicine 25: 1851-1857
Also see accompanying editorial:
Predicting health and life span with the deep plasma proteome (2019) V Emilsson, V Gudnason and LL Jennings.
Nature Medicine 25: 1815-1816 (SUBSCRIPTION REQUIRED)
Balanced event prediction through sampled survival analysis (2019) G Datta, LE Alexander, MA Hinterberg and Y Hagar.
Systems Medicine 2(1):28-38
Targeting unique epitopes on highly similar proteins GDF-11 and GDF-8 with modified DNA aptamers (2019) UA Ochsner, L Green, T Rice, E Olivas, N Janjic and E Katilius.
Biochemistry 58(46):4632-4640 (SUBSCRIPTION REQUIRED)
Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies (2019) A Alexaki, GK Hettiarachchi, JC Athey, UK Katneni, V Simhadri, N Hamasaki-Katagiri, P Nanavaty, B Lin, K Takeda, D Freedberg, D Monroe, JR Mcgill, R Peters, JM Kames, DD Holcomb, RC Hunt, ZE Sauna, A Gelinas, N Janjic, M Dicuccio, H Bar, AA Komar and C Kimchi-Sarfaty.
Scientific Reports 9(1): 15449
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study (2019) A Penn-Nicholson, T Hraha, EG Thompson, D Sterling, SK Mbandi, KM Wall, M Fisher, S Suliman, S Shankar, WA Hanekom, N Janjic, M Hatherill, SHE Kaufmann, J Sutherland, G Walzl, MA De Groote, U Ochsner, DE Zak, TJ Scriba, ACS and GC6–74 cohort study groups.
PLOS Medicine 16(4):e1002781
Proteomic profiles in advanced age-related macular degeneration using an aptamer-based proteomic technology (2019) AM Lynch, BD Wagner, SJ Weiss, KM Wall, AG Palestine, MT Mathias, FS Siringo, JN Cathcart, JL Patnaik, DW Drolet, N Janjic and N Mandava.
Translational Vision Science & Technology 8(1):14
Modified aptamers enable quantitative sub-10-nm cellular DNA-PAINT imaging (2018) S Strauss, PC Nickels, MT Strauss, VK Sabinina, J Ellenberg, JD Carter, S Gupta, N Janjic and R Jungmann.
Nature Methods 15(9):685-688
Also see accompanying editorial:
Improving probes for super-resolution (2018) RP Moore and WR Legant.
Nature Methods 15(9):659-660 (SUBSCRIPTION REQUIRED)
Genomic atlas of the human plasma proteome (2018) BB Sun, JC Maranville, JE Peters, D Stacey, JR Staley, J Blackshaw, S Burgess, T Jiang, E Paige, P Surendran, C Oliver-Williams, MA Kamat, BP Prins, SK Wilcox, ES Z, A Chi, N Bansal, SL Spain, AM Wood, NW Morrell, JR Bradley, N Janjic, DJ Roberts, WH Ouwehand, JA Todd, N Soranzo, K Suhre, DS Paul, CS Fox, RM Plenge, J Danesh, H Runz and AS Butterworth.
Sperm cell purification from mock forensic swabs using SOMAmer™ affinity reagents (2018) E Katilius, AB Carmel, H Koss, D O’Connell, BC Smith, GM Sanders and GS LaBerge.
Forensic Science International: Genetics 35:9-13 (SUBSCRIPTION REQUIRED)
The impact of the glomerular filtration rate on the human plasma proteome (2018) A Christensson, JA Ash, RK DeLisle, FW Gaspar, R Ostroff, A Grubb, V Lindström, L Bruum and SA Williams.
Proteomics Clinical Applications 12(3):e1700067 (SUBSCRIPTION REQUIRED)
Improving assessment of drug safety through proteomics: early detection and mechanistic characterization of the unforeseen harmful effects of torcetrapib (2018) SA Williams, AC Murthy, RK DeLisle, C Hyde, A Malarstig, R Ostroff, SJ Weiss, MR Segal and P Ganz.
Also see accompanying editorial:
Harnessing the power of proteomics to assess drug safety and guide clinical trials (2018) MPY Lam and Y Ge.
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease (2017) TJ Scriba, A Penn-Nicholson, S Shankar, T Hraha, EG Thompson, D Sterling, E Nemes, F Darboe, S Suliman, LM Amon, H Mahomed, M Erasmus, W Whatney, JL Johnson, W Boom, M Hatherill, J Valvo, MA De Groote, UA Ochsner, A Aderem, WA Hanekom, DE Zak and other members of the ACS cohort study team.
PLOS Pathogens 13(11):e1006687
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) KD Sullivan, D Evans, A Pandey, TH Hraha, KP Smith, N Markham, AL Rachubinski, K Wolter-Warmerdam, F Hickey, JM Espinosa and T Blumenthal.
Scientific Reports 7(1):14818
Pharmacokinetic properties of DNA aptamers with base modifications (2017) S Gupta, DW Drolet, SK Wolk, SM Waugh, JC Rohloff, JD Carter, WS Mayfield, MR Otis, CR Fowler, T Suzuki, M Hirota, Y Ishikawa, DJ Schneider and N Janjic.
Nucleic Acid Therapeutics 27(6):345-353
Structural basis for IL-1α recognition by a modified DNA aptamer that specifically inhibits IL-1α signaling (2017) X Ren, AD Gelina, I von Carlowitz, N Janjic and AM Pyle.
Nature Communications 8(1):810
Discovery of a six-marker serum protein signature for the diagnosis of pulmonary tuberculosis (2017) MA De Groote, DG Sterling, T Hraha, T Russell, LS Green, K Wall, S Kraemer, R Ostroff, N Janjic and UA Ochsner.
Journal of Clinical Microbiology 55(10):3057-3071
Potential of high-affinity, Slow Off-Rate Modified Aptamer (SOMAmer) reagents for Mycobacterium tuberculosis proteins as tools for infection models and diagnostic applications (2017) T Russell, LS Green, T Rice, NA Kruh-Garcia, K Dobos, MA De Groote, T Hraha, DG Sterling, N Janjic and UA Ochsner.
Journal of Clinical Microbiology 55(10):3072-3088
Development of a protein biomarker panel to detect non-small-cell lung cancer in Korea (2017) YJ Jung, E Katilius, RM Ostroff, Y Kim, M Seok, S Lee, S Jang, WS Kim and CM Choi.
Clinical Lung Cancer 18(2): e99-e107 (SUBSCRIPTION REQUIRED)
Selection of DNA aptamers with two modified bases (2017) BN Gawande, JC Rohloff, JD Carter, I von Carlowitz, C Zhang, DJ Schneider and N Janjic.
Proceedings of the National Academy of Sciences 114(11):2898-2903
Connecting genetic risk to disease end points through the human blood plasma proteome (2017) K Suhre, M Arnold, AM Bhagwat, RJ Cotton, R Engelke, J Raffler, H Sarwath, G Thareja, A Wahl, RK DeLisle, L Gold, M Pezer, G Lauc, MA El-Din Selim, DO Mook-Kanamori, EK Al-Dous, YA Mohamoud, J Malek, K Strauch, H Grallert, A Peters, G Kastenmüller, C Gieger and J Graumann.
Nature Communications 8:14357
Highly multiplexed proteomic analysis of quantiferon supernatants to identify biomarkers of latent tuberculosis infection (2017) MA De Groote, M Higgins, T Hraha, K Wall, ML Wilson, DG Sterling, N Janjic, R Reves, UA Ochsner and R Belknap.
Journal of Clinical Microbiology 55:391-402
Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease (2016) PJ Ganz, B Heidecker, K Hveem, C Jonasson, S Kato, MR Segal, DG Sterling and SA Williams.
Journal of the American Medical Association 315(23):2532-2541
Also see accompanying editorial:
Using aptamer-based technology to probe the plasma proteome for cardiovascular disease prediction (2016) M Sabatine.
Journal of the American Medical Association 315(23):2525-2526 (SUBSCRIPTION REQUIRED). For access to electronic version, please contact us.
Chemically modified interleukin-6 aptamer inhibits development of collagen-induced arthritis in cynomolgus monkeys (2016) M Hirota, I Murakami, Y Ishikawa, T Suzuki, S Sumida, S Ibaragi, H Kasai, N Horai, DW Drolet, S Gupta, N Janjic and DJ Schneider.
Nucleic Acid Therapeutics 26(1):10-19
Embracing proteins: structural themes in aptamer-protein complexes (2016) AD Gelinas, DR Davies and N Janjic.
Current Opinion in Structural Biology 36:122-32
Fit for the eye: aptamers in ocular disorders (2016) DW Drolet, LS Green, L Gold and N Janjic.
Nucleic Acid Therapeutics 26(3):127-146
Influence of 5-N-carboxamide modifications on the thermodynamic stability of oligonucleotides (2015) SK Wolk, RK Shoemaker, WS Mayfield, AL Mestdagh and N Janjic.
Nucleic Acids Research 43(19):9107-9122
Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts (2015) KA Olson, AL Beatty, B Heidecker, MC Regan, EN Brody, T Foremen, S Kato, RE Mehler, BS Singer, K Hveem, H Dalen, DG Sterling, RM Lawn, NB Schiller, SA Williams, MA Whooley and P Ganz.
European Heart Journal 36(48):3426-3434
Practical synthesis of cytidine-5-carboxamide-modified nucleotide reagents (2015) JC Rohloff, C Fowler, B Ream, JD Carter, G Wardle and T Fitzwater.
Nucleosides Nucleotides and Nucleic Acids 34(3):180-198
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy (2015) Y Hathout, E Brody, PR Clemens, L Cripe, RK DeLisle, P Furlong, H Gordish-Dressman, L Hache, E Henricson, EP Hoffman, YM Kobayashi, A Lorts, JK Mah, C McDonald, B Mehler, S Nelson, M Nikrad, B Singer, F Steele, D Sterling, HL Sweeney, S Williams and L Gold.
Proceedings of the National Academy of Sciences USA 112(23):7153-7158
Non-helical DNA triplex forms a unique aptamer scaffold for high affinity recognition of nerve growth factor (2015) TC Jarvis, DR Davies. A Hisaminato, DI Resnicow, S Gupta, SM Waugh, A Nagabukuro, T Wadatsu, H Hishigaki, B Gawande, C Zhang, SK Wolk, WS Mayfield, Y Nakaishi, AB Burgin, LJ Stewart, TE Edwards, AD Gelinas, DJ Schneider and N Janjic.
Circulating proteomic signatures of chronological age (2015) C Menni, SJ Kiddle, M Mangino, A Viñuela, M Psatha, C Steves, M Sattlecker, A Buil, S Newhouse, S Nelson, S Williams, N Voyle, H Soininen, I Kloszewska, P Mecocci, M Tsolaki, B Vellas, S Lovestone, TD Spector, R Dobson and AM Valdes.
Journal of Gerontology: Series A, Biological Sciences and Medical Sciences 70(7):809-816
Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents (2014) JC Rohloff, AD Gelinas, TC Jarvis, UA Ochsner, DJ Schneider, L Gold and N Janjic.
Molecular Therapy Nucleic Acids 3(10):e201
Specific capture and detection of Staphylococcus aureus with high-affinity modified aptamers to cell surface components (2014) A Baumstummler, D Lehmann, N Janjic and UA Ochsner.
Letters in Applied Microbiology 59(4):422-431
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis (2014) P Nahid, E Bliven-Sizemore, LG Jarlsberg, MA De Groote, JL Johnson, G Muzanyi, M Engle, M Weiner, N Janjic, DG Sterling and UA Ochsner.
Validation of a blood protein signature for non-small cell lung cancer (2014) M Mehan, SA Williams, JM Siegfried, WL Bigbee, JL Weissfeld, DO Wilson, HI Pass, WN Rom, T Muley, M Meister, W Franklin, YE Miller, EN Brody and RM Ostroff.
Clinical Proteomics 11(1):32
Alzheimer’s disease biomarker discovery using SOMAscan multiplexed protein technology (2014) M Sattlecker, SJ Kiddle, S Newhouse, P Proitsi, S Nelson, S Williams, C Johnston, R Killick, A Simmons, E Westman, A Hodges, H Soininen, I Kloszewska, P Mecocci, M Tsolaki, B Vellas, S Lovestone, AddNeuroMed Consortium and RJ Dobson.
Alzheimer’s & Dementia 10(6):724-734
Systematic selection of modified aptamer pairs for diagnostic sandwich assays (2014) UA Ochsner, LS Green, L Gold and N Janjic.
Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform (2014) J Webber, TC Stone, E Katilius, BC Smith, B Gordon, MD Mason, Z Tabi, IA Brewis and A Clayton.
Molecular & Cellular Proteomics 13(4):1050-1064
DTC-and-me: patient, provider, proteins and regulators (2014) F Steele and L Gold.
Journal of Personalized Medicine 4(1):79-87
Beyond antibodies: new affinity reagents to unlock the proteome (2014) B Lollo, F Steele and L Gold.
Crystal structure of interleukin-6 in complex with a modified nucleic acid ligand (2014) AD Gelinas, DR Davies, TE Edwards, JC Rohloff, JD Carter, C Zhang, S Gupta, Y Ishikawa, M Hirota, Y Nakaishi, TC Jarvis and N Janjic.
Journal of Biological Chemistry 289(12):8720-8734
Chemically-modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor (2014) S Gupta, M Hirota, SM Waugh, I Murakami, T Suzuki, M Muraguchi, M Shibamori, Y Ishikawa, TC Jarvis, JD Carter, C Zhang, B Gawande, M Vrkljan, N Janjic and DJ Schneider.
Journal of Biological Chemistry 289(12):8706-8719
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy (2013) FS Loffredo, ML Steinhauser, SM Jay, J Gannon, JR Pancoast, P Yalamanchi, M Sinha, C Dall’Osso, D Khong, JL Shadrach, CM Miller, BS Singer, A Stewart, N Psychogios, RE Gerszten, AJ Hartigan, MJ Kim, T Serwold, AJ Wagers and RT Lee.
Measurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on Slow Off-Rate Modified Aptamer (SOMAmer) reagents (2013) NJ Park, X Wang, A Diaz, DM Goos-Root, C Bock, JD Vaught, W Sun and CM Strom.
PLOS ONE 8(8):e71703
Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment (2013) MA De Groote, P Nahid, L Jarlsberg, JL Johnson, M Weiner, G Muzanyi, N Janjic, DG Sterling and UA Ochsner.
PLOS ONE 8(4):e61002
Interaction with both ZNRF3 and LGR4 is required for the signaling activity of R-spondin (2013) Y Xie, R Zamponi, O Charlat, M Ramones, S Swalley, X Jiang, D Rivera, W Tschatz, B Lu, L Quinn, C Dimitri, J Parker, D Jeffery, SK Wilcox, M Watrobka, P LeMotte, B Granda, JA Porter, VE Myer, A Loew and F Cong.
EMBO Reports 14(12):1120-1126
Candidate blood proteome markers of Alzheimer’s disease onset and progression: a systematic review and replication study (2013) SJ Kiddle, M Sattlecker, P Proitsi, A Simmons, E Westman, C Bazenet, SK Nelson, S Williams, A Hodges, C Johnston, H Soininen, I Kloszewska, P Mecocci, M Tsolaki, B Vellas, S Newhouse, S Lovestone and RJ Dobson.
Journal of Alzheimers Disease 38(3):515-531
Detection of Clostridium difficile toxins A, B, and binary toxin with slow off-rate modified aptamers (2013) UA Ochsner, E Katilius and N Janjic.
Diagnostic Microbiology and Infectious Disease 76(3):278-285 (SUBSCRIPTION REQUIRED)
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool (2012) RM Ostroff, MR Mehan, A Stewart, D Ayers, EN Brody, SA Williams, S Levin, B Black, M Harbut, M Carbone, C Goparaju and HI Pass.
PLOS ONE 7(10):e46091
Life’s simple measures: unlocking the proteome (2012) E Brody, L Gold, M Mehan, R Ostroff, J Rohloff, J Walker and D Zichi.
Journal of Molecular Biology 422(5):595-606 (SUBSCRIPTION REQUIRED)
Slow Off-Rate Modified Aptamer arrays for biomarker discovery and diagnostic applications (2012) JJ Walker, EN Brody and L Gold.
In “Microarrays in Diagnostics and Biomarker Development.” (Ed: B Jordan) Springer, ISBN 978-3-642-28202-7 (SUBSCRIPTION REQUIRED)
Protein signature of lung cancer tissues (2012) MR Mehan, D Ayers, D Thirstup, W Xiong, RM Ostroff, EN Brody, JJ Walker, L Gold, TC Jarvis, N Janjic, GS Baird and SK Wilcox.
PLOS ONE 7(4):e35157
Age-dependent changes in the cerebrospinal fluid proteome by Slow Off-Rate Modified Aptamer array (2012) GS Baird, SK Nelson, TR Keeney, A Stewart, S Williams, ER Peskind and TJ Montine.
American Journal of Pathology 180(2):446-456
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets (2012) DR Davies, AD Gelinas, C Zhang, JC Rohloff, JD Carter, D O’Connell, SM Waugh, SK Wolk, WS Mayfield, AB Burgin, TE Edwards, LJ Stewart, L Gold, N Janjic and TC Jarvis.
Proceedings of the National Academy of Sciences USA 109(49):19971-19976
From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay (2011) S Kraemer, JD Vaught, C Bock, L Gold, E Katilius, TR Keeney, N Kim, NA Saccamano, SK Wilcox, D Zichi and GM Sanders.
PLOS ONE 6(10):e26332
Making the cut: untangling clinical protein biomarker discovery and validation (2011) L Gold, S Williams, N Janjic, N Saccomano and F Steele.
Biomarkers in Medicine 5(2):189-191
Rapid histochemistry using Slow Off-rate Modified Aptamers with anionic competition. (2011) S Gupta, D Thirstrup, TC Jarvis, DJ Schneider, SK Wilcox, J Carter, C Zhang, A Gelinas, A Weiss, N Janjic and GS Baird.
Applied Immunohistochemistry & Molecular Morphology 19(3):273-8 (SUBSCRIPTION REQUIRED)
High-Content Affinity-Based Proteomics: Unlocking Protein Biomarker Discovery (2010) EN Brody, L Gold, RM Lawn, JJ Walker and D Zichi.
Expert Review of Molecular Diagnostics 10(8):1013-1022
Aptamers and the RNA world, past and present (2010) L Gold, N Janjic, T Jarvis, DD Schneider, JJ Walker, SK Wilcox and D Zichi.
Cold Spring Harbor Perspectives in Biology 4(3):a003582
Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer (2010) RM Ostroff, WL Bigbee, W Franklin, L Gold, M Mehan, YE Miller, HI Pass, WN Rom, JM Siegfried, A Stewart, JJ Walker, JL Weissfeld, SA Williams, D Zichi and EN Brody.
PLOS ONE 5(12):e15003
Expanding the chemistry of DNA for in vitro selection (2010) JD Vaught, C Bock, J Carter, T Fitzwater, M Otis, D Schneider, J Rolando, S Waugh, SK Wilcox and B Eaton.
Journal of the American Chemical Society 132(12):4141–4151 (SUBSCRIPTION REQUIRED)
The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. (2010) R Ostroff, T Foreman, TR Keeney, S Stratford, JJ Walker and D Zichi.
Journal of Proteomics 73(3):649-66 (SUBSCRIPTION REQUIRED)
Aptamer-based multiplexed proteomic technology for biomarker discovery (2010) L Gold, D Ayers, J Bertino, C Bock, A Bock, EN Brody, J Carter, AB Dalby, BE Eaton, T Fitzwater, D Flather, A Forbes, T Foreman, C Fowler, B Gawande, M Goss, M Gunn, S Gupta, D Halladay, J Heil, J Heilig, B Hicke, G Husar, N Janjic, T Jarvis, S Jennings, E Katilius, TR Keeney, N Kim, TH Koch, S Kraemer, L Kroiss, N Le, W Lindsey, B Lollo, W Mayfield, M Mehan, R Mehler, M Nelson, SK Nelson, D Nieuwlandt, M Nikrad, U Ochsner, RM Ostroff, M Otis, T Parker, S Pietrasiewicz, DI Resnicow, J Rohloff, G Sanders, S Sattin, D. Schneider, B Singer, M Stanton, A Sterkel, A Stewart, S Stratford, JD Vaught, M Vrkljan, JJ Walker, M Watrobka, S Waugh, A Weiss, SK Wilcox, A Wolfson, SK Wolk, C Zhang and D Zichi.
PLOS ONE 5(12):e15004
Proteomics and diagnostics: let’s get specific, again (2008) D Zichi, B Eaton, B Singer and L Gold.
Current Opinion in Chemical Biology 12(1):78–85. (SUBSCRIPTION REQUIRED).
Aptamers: the new frontier in drug development? (2007) B Carlson.
Biotechnology Healthcare 4(2):31-36.
Aptamers as therapeutic and diagnostic agents (2000) EN Brody and L Gold.
Reviews in Molecular Biotechnology 74(1):5-13. (SUBSCRIPTION REQUIRED).
High affinity ligands from in vitro selection: complex targets. (1998) KN Morris, KB Jensen, CM Julin, M Weil and L Gold.
Proceedings of the National Academy of Sciences USA 95(6):2902-2907.
Let’s get specific: The relationship between specificity and affinity (1995) BE Eaton, L Gold and DA Zichi.
Chemistry & Biology 2(10):633-638.
Systematic evolution of ligands by exponential enrichment: RNA Ligands to bacteriophage T4 DNA polymerase (1990) C Tuerk and L Gold.
Science 249(4968):505-510. (SUBSCRIPTION REQUIRED).